World
Politics
Business
Investing

Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Pinterest Email

previous post

5 Biggest Blockchain ETFs in 2025

next post

UAE AMBASSADOR YOUSEF AL OTAIBA: US and UAE forge groundbreaking high-tech partnership based on AI

Related Posts

Metals Focus: Gold to Average US$3,210 in 2025 as Central...

June 6, 2025

Silver Price Surges to US$36, Marking 13 Year High

June 6, 2025

Auto Industry Takes Hit as China’s Rare Earths Export Controls Impact...

June 6, 2025

Retraction of Lo Herma Scoping Study Statements

June 6, 2025

In-fill RC Drilling at Kamperman Confirms High-Grade Gold

June 6, 2025

Offer Booklet – Non-Renounceable Entitlement Offer

June 6, 2025

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent

What we know about the countries on Trump’s travel ban list, and how many people will be impacted

June 6, 2025
Israel strikes southern suburb in Beirut

June 6, 2025
What is D-Day? How the Normandy landings led to Germany’s defeat in World War II

June 6, 2025
Russia launches aerial assault on Kyiv days after Ukraine’s audacious drone attack on bomber fleet

June 6, 2025
North Korea refloats destroyer that capsized during launch, surprising naval analysts

June 6, 2025

Categories

Business (1,393)
Investing (3,399)
Politics (4,546)
World (4,458)

Email Whitelisting
Terms and Conditions
Privacy Policy
Contacts
About us

Disclaimer: EconomicRulesHub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 EconomicRulesHub.com | All Rights Reserved

World
Politics
Business
Investing